At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 182 enrolled
Drug / intervention
BRIMOCHOL™ PF +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia
In Brief
A Phase 3 clinical trial evaluating BRIMOCHOL™ PF, Carbachol PF, and 1 other intervention for Presbyopia. Completed, enrolled 182 participants across 15 sites.
Detailed Summary
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2023202420252026
First PostedMar 2022
Enrollment StartMar 2022
Primary CompletionMar 2023
Study CompletionApr 2023
TodayJul 2026
First PostedMar 8, 2022
Enrollment StartMar 30, 2022
Primary CompletionMar 17, 2023
Study CompletionApr 10, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.3 years ago
Interventions
BRIMOCHOL™ PFdrug
A single drop in each eye at a visit.
Carbachol PFdrug
A single drop in each eye at a visit.
Brimonidine tartratedrug
A single drop in each eye at a visit.